Placing a Bet: New Therapy for Parkinson's Disease
2016
This module is intended for use by business school students. It examines the decision-making process at a pharmaceutical company as its chief operating officer decides whether to invest in the development and licensing of a promising treatment for Parkinson’s disease.
The module is structured around a drug development case that provides students with opportunities to: (1) analyze a rich and realistic description of the complex scientific and medical results associated with a promising therapeutic molecule and to consider whether the molecule warrants further investment; (2) examine the failure of clinical trials and consider why new trials utilizing a different delivery mechanism might succeed; (3) consider how a bid is structured and examine the trade-offs involved when making bid element choices; and (4) construct a best-case scenario for the further drug development.
This module is one of 9 modules developed by the Committee on Preparing the Next Generation of Policy Makers for Science-Based Decisions, an ad hoc committee under the auspices of the National Academies of Sciences, Engineering, and Medicine’s Committee on Science, Technology, and Law. The modules were developed for students of law, public policy, medicine, journalism and business, and are intended to provide early exposure to materials that elucidate the role that scientific information and scientific processes play in decision-making across diverse venues. Access all modules.
Placing a Bet: New Therapy for Parkinson's Disease
Source:
Sharer KW. Placing a Bet: A New Therapy for Parkinson’s Disease. An Educational Module. The National Academies of Sciences, Engineering, Medicine 2016. https://www.nationalacademies.org/documents/embed/link/LF2255DA3DD1C41C0A42D3BEF0989ACAECE3053A6A9B/file/DE0090C2716685EA0A9950495CD0FAE57BF6B27E4CB3?noSaveAs=1